Literature DB >> 21234041

Neonatal screening part 2: neonatal screening in Canada.

B A Morris.   

Abstract

Neonatal screening is a widely accepted, cost-effective method for early detection of various inborn errors of metabolism. This series of three articles examines different aspects of neonatal screening. In the first article, the author discussed general principles of screening and its function in the spectrum of diagnostic techniques for genetic disease. In this, the second article, the author reviews the history and current practices of neonatal screening in Canada. The individual diseases for which screening is used and particular points of interest for each of these diseases are briefly described. The author also outlines the benefits of screening and treatment. In the final article of this series, the author will examine controversial topics that represent the possible future of screening.

Entities:  

Year:  1990        PMID: 21234041      PMCID: PMC2280648     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  12 in total

1.  Experience of the Manitoba Perinatal Screening Program, 1965-85.

Authors:  J G Fox
Journal:  CMAJ       Date:  1987-11-15       Impact factor: 8.262

2.  Intellectual outcome in children with fetal hypothyroidism.

Authors:  J Rovet; R Ehrlich; D Sorbara
Journal:  J Pediatr       Date:  1987-05       Impact factor: 4.406

Review 3.  Effectiveness of newborn screening programs for congenital hypothyroidism: prevalence of missed cases.

Authors:  D A Fisher
Journal:  Pediatr Clin North Am       Date:  1987-08       Impact factor: 3.278

4.  Correlation of ovarian function with galactose-1-phosphate uridyl transferase levels in galactosemia.

Authors:  F R Kaufman; Y K Xu; W G Ng; G N Donnell
Journal:  J Pediatr       Date:  1988-05       Impact factor: 4.406

5.  Congenital hypothyroidism and growth hormone deficiency.

Authors:  F De Zegher; M Vanderschueren-Lodeweyckx; P Suarez; L Dooms; J Kimpen; P Malvaux
Journal:  Lancet       Date:  1988 Dec 24-31       Impact factor: 79.321

6.  Childhood chronic disease and family functioning: a study of phenylketonuria.

Authors:  A E Kazak; M Reber; L Snitzer
Journal:  Pediatrics       Date:  1988-02       Impact factor: 7.124

7.  Should we screen for congenital adrenal hyperplasia? A review of 117 cases.

Authors:  N K Virdi; P H Rayner; B T Rudd; A Green
Journal:  Arch Dis Child       Date:  1987-07       Impact factor: 3.791

8.  Timing of strict diet in relation to fetal damage in maternal phenylketonuria. An international collaborative study by the MRC/DHSS Phenylketonuria Register.

Authors:  E Drogari; I Smith; M Beasley; J K Lloyd
Journal:  Lancet       Date:  1987-10-24       Impact factor: 79.321

9.  Clinical findings in four children with biotinidase deficiency detected through a statewide neonatal screening program.

Authors:  B Wolf; G S Heard; L G Jefferson; V K Proud; W E Nance; K A Weissbecker
Journal:  N Engl J Med       Date:  1985-07-04       Impact factor: 91.245

10.  Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  S Y Pang; M A Wallace; L Hofman; H C Thuline; C Dorche; I C Lyon; R H Dobbins; S Kling; K Fujieda; S Suwa
Journal:  Pediatrics       Date:  1988-06       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.